Biotech Startups

1 investor

Plaxin develops a bioplastic material designed as an alternative to conventional plastic to address environmental concerns. The company focuses on producing sustainable materials for industrial applications.

1 investor

A regenerative medicine company developing platform technologies and products for the bio and medical regeneration industry, applying research in skin and tissue regeneration to improve quality of life. Its work is led by plastic surgery clinical and research faculty.

1 investor

Pleioflow develops minimally invasive flow assist devices designed to prevent renal failure in cardiac surgery patients and those experiencing acute kidney injury. The company focuses on medical devices for cardiac assist and renal protection applications.

1 investor

PlenaryAI builds customized artificial intelligence tools for physicians and clinical staff, combining biomarkers and multi-modality imaging with data analytics to support clinical decisions for patients. The company focuses on precision health for the biomedical and healthcare sector.

1 investor

PleoPharma is a pharmaceutical company developing a treatment aimed at an unmet medical condition. It works with industry partners, healthcare providers, researchers, and investors.

1 investor

Pleural Dynamics develops medical implant devices for patients with recurrent pleural effusions. Its ACES (Automatic Continuous Effusion Management System) implant shunts fluid to relieve symptomatic recurrent pleural effusion.

1 investor

SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers. The company serves laboratories, diagnostic companies, biotechs, and pharmaceutical firms through technology licensing, custom assay development, and partnership services.

1 investor

Pliant Therapeutics is a clinical-stage biopharmaceutical company developing integrin-based therapeutics to treat serious diseases. The company focuses on understanding integrin biology and molecular mechanisms of pathology to create safer and more effective therapies for patients.

1 investor

PLT develops human tissue organoids produced in microgravity conditions for use in pharmaceutical testing, precision medicine, and transplantation research. The company manufactures these 3D tissue cultures from stem cells and is developing hardware for commercial-scale organoid production in space.

1 investor

Plurify develops manufacturing technology for advanced therapies, specifically cell and gene therapy production. The company's platform addresses scalability, safety, and cost challenges in bioreactor-scale therapeutic manufacturing.

1 investor

Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders. Its lead program, PBAS499, targets phenylketonuria (PKU), an inborn metabolic disorder, with plans to apply its drug discovery platform to other protein-misfolding diseases.

1 investor

Pharmaceutical company developing pulmonary drug therapies with a COPD device and digital delivery platform.

1 investor

Polari Group is a biotech company focused on infectious disease research and product development, leveraging scientific expertise in virology, bioengineering, and microfluidics.

1 investor

Polari Labs develops A-BALL, a body-safe insertable device positioned as an alternative to anal douching that acts as a barrier and dissolves into a stool-like texture for later removal. The company is building a lab focused on the science of anal intimacy products, based in London.

1 investor

POLBIOTECH LABORATORIUM provides biotechnological monitoring and analysis services for biogas plants, helping operators optimize methane fermentation processes through accredited lab testing and expert consulting. The company serves biogas facility managers and developers in Poland with sample analysis, production forecasting, and operational problem-solving.

1 investor

PolimerBio develops biodegradable bioplastics, including new polyesters and sugar-based nanostructured additives intended to speed degradation, improve mechanical properties, and add antimicrobial capability. It participates in the AcroBioPLAST project, which aims to develop a medical device prototype for preclinical validation.

1 investor

Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.

1 investor

PolyActiva develops biodegradable ophthalmic drug-delivery therapies for blinding eye diseases, including rare pediatric retinal conditions with no approved treatments. It uses its PREZIA platform to create new chemical entity-eligible pro-drug candidates.

1 investor

PolyAn manufactures functionalized surfaces for life-science applications, including microarray glass slides, coverslips, plates, films and membranes, color-encoded PMMA micro- and nanoparticles, and functionalized microplates for immobilizing biomolecules. It serves laboratories and researchers working with immunoassays, PCR, multiplex bead assays, flow cytometry and microscopy, and offers custom Molecular Surface Engineering services.

1 investor

Polymathic AI develops foundation models and machine learning for scientific data, aiming to build models that reuse shared concepts across disciplines for researchers. Its work includes an AI agent that determines organic molecular structure from raw experimental NMR data by treating the task as a constrained search over chemical space.

1 investor

Polymedco is a healthcare company that develops and sells noninvasive diagnostic tests, including fecal immunochemical tests for colorectal cancer screening and cardiac biomarker analyzers for urgent care. Its products serve laboratories, screening programs, and healthcare systems.

1 investor

Polymera develops biodegradable superabsorbent materials made from biopolymers produced by Antarctic bacteria, intended as a sustainable alternative to petroleum-based sodium polyacrylate used in the absorbent cores of disposable hygiene products such as diapers.

1 investor

A company that has completed first-in-human clinical trials for its products and is pursuing regulatory approvals for worldwide commercialization.

1 investor